Event Overview

The FT Global Pharmaceutical and Biotechnology Conference is the benchmark event for the industry, attended by senior executives and financial professionals from around the world. Entitled ‘Transforming the Pharma Business for Growth’ and starting on 9 November 2020 at 1pm GMT with a keynote address from the CEO of Sanofi, there follows three days of high-level content involving the biggest names in pharma and biotech. Skillfully moderated by our expert correspondents for over 38 years now, our 2020 conference brings together yet another outstanding lineup of speakers but in the form of a global digital conference.

Digitally connect with over 1,500 of the most influential players in the global pharma-bio industry

Hear from industry decision-makers as leading pharmaceutical CEOs debate about the effects of Covid-19 online

Built upon a 38-year track record of trusted and successful healthcare conferences

Two days of FT-curated content designed to help re-shape the pharma pipeline for growth

Bringing a unique digital dimension to pharma-bio’s premier industry event

Senior Director, Astellas
“Good speakers and brilliant for networking”

Confirmed speakers include:

Bélén Garijo,

CEO - Healthcare,

Merck

Paul Hudson,

CEO,

Sanofi

Sarah Wilkinson,

CEO,

NHS Digital

Susanne Schaffert,

President - Oncology,

Novartis

José Baselega,

Executive Vice President - R&D,

AstraZeneca

Alex Borisy,

Founder, Chairman and CEO,

EQRx

1500+ attendees
50+ speakers
37% C-suite/Board member level attendees